Publications by authors named "Peter Spiegler"

Claim this Profile
L
Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure.
Juri Chung, Shari B Brosnahan, Shahidul Islam, Diana Altshuler, Peter Spiegler

J Crit Care· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 33-Year-Old Man With Acute Hemoptysis.
Erin Meier, Douglas S Katz, Peter Spiegler

Chest· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of propofol infusion syndrome in critically-ill patients.
Wai Kin Li, Xian Jie Cindy Chen, Diana Altshuler, Shahidul Islam, Peter Spiegler

J Crit Care· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation.
Bonnie E Lonze, Peter Spiegler, Russell N Wesson, Nada Alachkar, Eva Petkova

Crit Care Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
Xian Jie Cindy Chen, Diana Altshuler, Peter Spiegler, Shari B Brosnahan

Ann Pharmacother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
Shari B Brosnahan, Xian Jie Cindy Chen, Juri Chung, Diana Altshuler, Shahidul Islam, Peter Spiegler

Ann Pharmacother· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic pulmonary fibrosis: Current and future treatment.
Daniel S Glass, David Grossfeld, Heather A Renna, Priya Agarwala, Peter Spiegler

Clin Respir J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches.
Daniel S Glass, David Grossfeld, Heather A Renna, Priya Agarwala, Peter Spiegler

Respir Investig· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of suspected pulmonary embolism and deep venous thrombosis in obese patients.
Vincent Cascio, Man Hon, Linda B Haramati, Animesh Gour, Peter Spiegler

Br J Radiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
Donald A Brand, Patricia A Patrick, Jeffrey T Berger, Mediha Ibrahim, Ajsza Matela, Peter Spiegler

J Pain Symptom Manage· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible hepatotoxicity associated with intravenous acetaminophen in a 36-year-old female patient.
Philip J Lee, Mark Shen, Shan Wang, Peter Spiegler, Thomas Caraccio

P T· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic pneumonia associated with azacitidine in a patient with myelodysplastic syndrome.
Girish B Nair, Melissa Charles, Lorna Ogden, Peter Spiegler

Respir Care· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Written disclosure therapy for patients with chronic lung disease undergoing pulmonary rehabilitation.
Manoochehr Abadian Sharifabad, Adam Hurewitz, Peter Spiegler, Mara Bernstein, Martin Feuerman

J Cardiopulm Rehabil Prev· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.
Jonathan Ilowite, Peter Spiegler, Heather Kessler

Drugs· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchiectasis: new findings in the pathogenesis and treatment of this disease.
Jonathan Ilowite, Peter Spiegler, Shalinee Chawla

Curr Opin Infect Dis· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiology-Pathology Conference: pulmonary hyalinizing granuloma associated with lupus-like anticoagulant and Morvan's Syndrome.
David I Winger, Peter Spiegler, Terence K Trow, Amit Goyal, Huiying Yu

Clin Imaging· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of pulmonary rehabilitation on healthcare utilization in chronic obstructive pulmonary disease: The Northeast Pulmonary Rehabilitation Consortium.
Jonathan Raskin, Peter Spiegler, Corliss McCusker, Richard ZuWallack, Mara Bernstein

J Cardiopulm Rehabil· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease.
Gregory Ferreira, Martin Feuerman, Peter Spiegler

J Cardiopulm Rehabil· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid pleurodesis for malignant pleural effusions.
Peter A Spiegler, Adam N Hurewitz, Maritza L Groth

Chest· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis